Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hepatocytes
100%
Fatty Liver Disease
100%
Mitochondrial Amidoxime Reducing Component
100%
Knockdown
75%
Non-alcoholic Fatty Liver Disease (NAFLD)
62%
Human Genetics
37%
Hepatocyte-specific
37%
Genetic Variants
25%
Primary Hepatocytes
25%
Mendelian Randomization
25%
Adverse Effects
12%
Metabolic
12%
Lipid Composition
12%
Specific Targeting
12%
Therapeutic Potential
12%
Mouse Model
12%
Method Analysis
12%
Plasma Lipids
12%
Effective Treatment
12%
Colocalization
12%
Nonalcoholic Steatohepatitis
12%
Lipid Metabolism
12%
Disease-specific Mortality
12%
N-acetylgalactosamine
12%
New Therapeutics
12%
Body Composition
12%
Serum Triglycerides
12%
Liver Enzymes
12%
Pathophysiological Roles
12%
Genetic Association
12%
Hepatic Steatosis
12%
Amylin
12%
Public Health Impact
12%
3-hydroxybutyrate
12%
Lipid Accumulation
12%
Liver Fat
12%
Therapeutic Inhibitors
12%
Liver Health
12%
Hepatocyte Model
12%
Triglyceride Secretion
12%
GalNAc-siRNA
12%
Liver-related Mortality
12%
Multi-trait
12%
Causal Variant
12%
Nash Model
12%
Genetically Predicted
12%
Biochemistry, Genetics and Molecular Biology
Hepatocyte
100%
Human Genetics
42%
Secretion (Process)
28%
Genetic Divergence
28%
Messenger RNA
28%
Enzyme
14%
In Vivo Study
14%
Triglyceride
14%
Lipid Composition
14%
Mouse Model
14%
Prevalence
14%
Blood Lipids
14%
Murine
14%
Lipid Metabolism
14%
N-Acetylgalactosamine
14%
Lipid Storage
14%
Body Composition
14%
Triacylglycerol Blood Level
14%
Genetic Association
14%
Amylin
14%
Small Interfering RNA
14%
Colocalization
14%
Adverse Effect
14%